首页 | 本学科首页   官方微博 | 高级检索  
检索        

泌尿生殖道炎症病人支原体感染现况及耐药性分析
引用本文:严子禾,周敏,张雯,张德邻.泌尿生殖道炎症病人支原体感染现况及耐药性分析[J].中华男科学杂志,2003,9(8):599-600,603.
作者姓名:严子禾  周敏  张雯  张德邻
作者单位:无锡市第二人民医院检验科,江苏,无锡,214002
摘    要:目的 :了解泌尿生殖道炎症病人支原体感染现况及耐药性情况。 方法 :统计 1999~ 2 0 0 3年门诊诊断为非淋菌性尿道炎 (NGU)、慢性前列腺炎及盆腔炎等泌尿生殖道疾病病人 30 5 5例 ,分析其支原体培养及药物敏感试验结果。 结果 :30 5 5例病人共检出支原体感染 992例 ( 32 .5 % ) ,5年间差异无显著性 (P <0 .0 5 )。其中单纯溶脲脲原体 (Uu)感染 70 1例 ( 70 .7% ) ,单纯人型支原体 (Mh)感染 4 4例 ( 4 .4 % ) ,Uu和Mh混合感染 2 4 7例 ( 2 4 .9% ) ,单纯Uu感染远高于混合感染和单纯Mh感染 (P <0 .0 1)。单纯Uu感染计数≥ 10 4cfu/ml占 76 .7% ,而单纯Mh感染者≥10 4cfu仅占 18.2 %。对强力霉素、原始霉素、交沙霉素和四环素敏感性较高 ,分别为 94 .3%、96 .6 %、86 .5 %和97.4 % ,对红霉素和氧氟沙星敏感性仅 5 4 .8%和 2 9.4 %。 结论 :在对病人进行支原体检测时 ,应同时进行Uu和Mh的检测 ,并做支原体药物敏感试验 ,以合理选择抗生素。

关 键 词:泌尿生殖道  炎症  支原体  溶脲脲原体  人型支原体
文章编号:1009-3591(2003)08-0599-03

Prevalence and Drug Tolerance of Mycoplasma in Patients with Urogenital Inflammation
Zi He YAN,Min ZHOU,Wen ZHANG,De Lin ZHANG.Prevalence and Drug Tolerance of Mycoplasma in Patients with Urogenital Inflammation[J].National Journal of Andrology,2003,9(8):599-600,603.
Authors:Zi He YAN  Min ZHOU  Wen ZHANG  De Lin ZHANG
Institution:Department of Laboratory Science, Wuxi Second People's Hospital, Wuxi, Jiangsu 214002, China.
Abstract:OBJECTIVE: To observe the prevalence and drug tolerance of mycoplasma(Ureaplasma urealyticum and Mycoplasma hominis) in patients with urogenital inflammation. METHODS: Three thousand and fifty-five patients with urogenital inflammation such as non-gonococcal urethritis(NGU), chronic prostatitis or pelvic inflammation from 1999 to 2003 were included. The results of mycoplasma culture and drug sensitivity test were analyzed. RESULTS: A total of 992(32.5%) cases were mycoplasma positive in the 3,055 patients, and there was no significant difference in the yearly positive percentage in the 5 years (P < 0.05). Among them, 701(70.7%) were infected with Ureaplasma urealyticum, 44(4.4%) with Mycoplasma hominis, and 247(24.9%) with both Ureaplasma urealyticum and Mycoplasma hominis, the Ureaplasma urealyticum infection rate being much higher than that of Mycoplasma hominis and mixed infection (P < 0.01). The high colony counting(> or = 10(4) cfu/ml) in Ureaplasma urealyticum infection patients accounted for 76.7%, while Mycoplasma hominis infection represented only 18.2%. The results of drug tolerance test showed a higher sensitivity to doxycycline, pristinamycin, josamycin and tetracycline (94.3%, 96.6%, 86.5% and 97.4% respectively), and a lower sensitivity to erythromycin and ofloxacin (54.8% and 29.4% respectively). CONCLUSIONS: Ureaplasma urealyticum and Mycoplasma hominis should be detected simultaneously and the drug tolerance test is needed for the selection of appropriate antibiotics.
Keywords:Urogenital duct  Inflammation  Mycoplasma  Ureaplasma urealyticum  Mycoplasma hominis
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号